VIM and synucleinopathy: The discrepancy in the sensitivity of vimentin antibodies to detect truncated forms in different models, such as hiPSC-derived neurons, postmortem PD brains, and synucleinopathy mouse models, may result from variations in truncation sites, protease involvement, and the degree of vimentin cleavage in each system.